Quantum BioPharma Ltd. (QNTM) — Strategic Asset Allocation Index
Quantum BioPharma Ltd. (QNTM) has a Strategic Asset Allocation Index of 0.0% as of December 2025. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $5.09 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Quantum BioPharma Ltd. to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Quantum BioPharma Ltd. Strategic Asset Allocation Index (2020–2025)
This chart shows how Quantum BioPharma Ltd.'s Strategic Asset Allocation Index has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $5.09 Million USD. For live market cap and overall valuation, see Quantum BioPharma Ltd. market cap and net worth.
Annual Strategic Asset Allocation Index for Quantum BioPharma Ltd. (2020–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for Quantum BioPharma Ltd. from 2020 to 2025, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Quantum BioPharma Ltd. shareholders equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.0% | $0.00 | $- | $0.00 | $5.09 Million | ▼ 0.0 pp |
| 2024 | 0.0% | $2.22K | $- | $2.22K | $10.44 Million | ▼ 0.0 pp |
| 2023 | 0.0% | $6.05K | $- | $6.05K | $12.91 Million | ▼ -2.7 pp |
| 2022 | 2.7% | $827.61K | $- | $827.61K | $30.54 Million | ▲ +1.5 pp |
| 2021 | 1.2% | $660.23K | $- | $660.23K | $54.13 Million | ▼ -3.4 pp |
| 2020 | 4.6% | $1.68 Million | $- | $1.68 Million | $36.31 Million | — |